CLASS II Device recall · Reported 27 Oct 2021 · FDA Enforcement Report

Signa Creator, Signa Explorer nuclear magnetic resonance recalled

GE Healthcare is recalling Signa Creator, Signa Explorer nuclear magnetic resonance imaging system, distributed in 19 states. The recall was initiated on 26 Aug 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware version DV29.1
Quantity recalled6 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0137-2022
FDA event ID
88665
Recalling firm
GE Healthcare, Waukesha, WI
Classification
Class II
Status
Terminated
Recall initiated
26 Aug 2021
FDA classified
16 Oct 2021
Reported
27 Oct 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

26 Aug 2021Recall initiated by company
16 Oct 2021Classified by FDA+51 days
27 Oct 2021Published in enforcement report+11 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Under certain conditions, some slices may be missing which can lead to a gap of anatomy in the 3D Volume images.

Product as listed by the FDA

SIGNA Creator, SIGNA Explorer nuclear magnetic resonance imaging system

Where it was distributed

Distribution in United States to AZ, CA, FL, GA, IL, LA, MA, MD, MN, NC, NH, NJ, NY, OH, OK, TX, VA, WA, and Puerto Rico OUS distribution to: Australia, Belgium, Canada, Chile, Colombia, France, Germany, Italy, Japan, Korea, Poland, Saudi Arabia, Spain, Sweden, Turkey, UAE, and UK

ArizonaCaliforniaFloridaGeorgiaIllinoisLouisianaMassachusettsMarylandMinnesotaNorth CarolinaNew HampshireNew JerseyNew YorkOhioOklahomaPuerto RicoTexasVirginiaWashington

Questions about this recall

Why was it recalled?

Under certain conditions, some slices may be missing which can lead to a gap of anatomy in the 3D Volume images.

Which lots are affected?

Software version DV29.1

Where was it sold?

Distribution in United States to AZ, CA, FL, GA, IL, LA, MA, MD, MN, NC, NH, NJ, NY, OH, OK, TX, VA, WA, and Puerto Rico OUS distribution to: Australia, Belgium, Canada, Chile, Colombia, France, Germany, Italy, Japan, Korea, Poland, Saudi Arabia, Spain, Sweden, Turkey, UAE, and UK

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

9 other products · FDA event 88665

This product is part of a recall event; the main page for the event is Signa Pioneer nuclear magnetic resonance imaging system recalled.

More recalls from GE Healthcare

All 512

Other Imaging Equipment recalls

All 2,336